艾德生物
(300685)
| 流通市值：81.07亿 | | | 总市值：81.18亿 |
| 流通股本：3.90亿 | | | 总股本：3.90亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 559,346,697.42 | 260,346,165.81 | 1,197,733,641.14 | 865,632,981.04 |
| 营业总成本 | 374,220,703.18 | 168,270,302.9 | 784,423,277.66 | 560,748,986.69 |
| 其他经营收益 | | | | |
| 营业利润 | 190,409,736.77 | 98,055,121.45 | 417,426,251.86 | 306,392,696.26 |
| 利润总额 | 186,678,826.74 | 95,891,418.97 | 410,920,550.46 | 300,817,448.37 |
| 净利润 | 166,125,204.53 | 85,156,924.42 | 361,255,321.05 | 262,505,939.1 |
| 每股收益 | | | | |
| 其他综合收益 | -1,650,907.61 | - | 125,146.33 | 106,770.02 |
| 综合收益总额 | 164,474,296.92 | 85,156,924.42 | 361,380,467.38 | 262,612,709.12 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,927,663,541.47 | 2,110,689,965.81 | 2,052,938,923.64 | 1,995,678,659.23 |
| 非流动资产: | | | | |
| 非流动资产合计 | 287,023,461.4 | 286,222,356.13 | 294,696,462.69 | 250,496,885.42 |
| 资产总计 | 2,214,687,002.87 | 2,396,912,321.94 | 2,347,635,386.33 | 2,246,175,544.65 |
| 流动负债: | | | | |
| 流动负债合计 | 125,007,005.89 | 139,396,813 | 178,118,020.46 | 182,725,828.21 |
| 非流动负债: | | | | |
| 非流动负债合计 | 195,467,622.78 | 199,912,944.15 | 113,570,961.6 | 104,527,586.02 |
| 负债合计 | 320,474,628.67 | 339,309,757.15 | 291,688,982.06 | 287,253,414.23 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,894,212,374.2 | 2,057,602,564.79 | 2,055,946,404.27 | 1,958,922,130.42 |
| 股东权益合计 | 1,894,212,374.2 | 2,057,602,564.79 | 2,055,946,404.27 | 1,958,922,130.42 |
| 负债和股东权益合计 | 2,214,687,002.87 | 2,396,912,321.94 | 2,347,635,386.33 | 2,246,175,544.65 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 655,146,926.84 | 341,274,557.11 | 1,252,647,501.42 | 916,140,935.3 |
| 经营活动现金流出小计 | 460,441,301.18 | 233,986,599.88 | 887,823,441.91 | 640,754,341.83 |
| 经营活动产生的现金流量净额 | 194,705,625.66 | 107,287,957.23 | 364,824,059.51 | 275,386,593.47 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 405,735,106.26 | 153,105,337.5 | 293,828,146.14 | 268,871,410.51 |
| 投资活动现金流出小计 | 358,784,637.6 | 331,794,983.25 | 525,725,831.17 | 393,551,988.29 |
| 投资活动产生的现金流量净额 | 46,950,468.66 | -178,689,645.75 | -231,897,685.03 | -124,680,577.78 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 94,000,000 | 94,000,000 | 101,678,234.6 | 90,153,559.36 |
| 筹资活动现金流出小计 | 351,701,904.28 | 85,835,898.13 | 203,381,280.86 | 199,158,713.7 |
| 筹资活动产生的现金流量净额 | -257,701,904.28 | 8,164,101.87 | -101,703,046.26 | -109,005,154.34 |
| 汇率变动对现金及现金等价物的影响 | -32,426,556.57 | -12,942,140.83 | -5,142,146.98 | 3,602,104.04 |
| 现金及现金等价物净增加额 | -48,472,366.53 | -76,179,727.48 | 26,081,181.24 | 45,302,965.39 |
| 期末现金及现金等价物余额 | 293,070,650.53 | 265,363,289.58 | 341,543,017.06 | 360,764,801.21 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -48,472,366.53 | - | 26,081,181.24 | - |
最新报告期：2026-09-14| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 东方证券 | 伍云飞 | 0.97 | 1.16 | 1.37 | 2026-09-14 |